The lack of difference in pruritus intensity between group 1 and group 2 of patients may be due to the broad range of pruritogens in AD, such as IL-13 or IL-4 (1), which could promote the itch signaling pathway in patients that do not produce IL-31 upon HDM stimulation. This evidence concerns the gene IL4 and Alzheimer disease.